NLRP3 and neurodegenerative disease: Given the recent interest in using NLRP3 inflammasome inhibitors as therapeutics against neurodegenerative diseases, and the promising outcomes of these molecules in mouse models, a better understanding on the role of cytokines in NLRP3 inflammasome activation could provide valuable insights into the pathogenesis of bvFTD and its diagnosis and treatment.